For every two deaths attributed to COVID-19 in the U.S., a third American dies as a result of the pandemic, according to new data publishing Oct. 12 in the Journal of the American Medical Association.
The study, led by researchers at Virginia Commonwealth University, shows that deaths between March 1 and Aug. 1 increased 20% compared to previous years — maybe not surprising in a pandemic. But deaths attributed to COVID-19 only accounted for 67% of those deaths.
“Contrary to skeptics who claim that COVID-19 deaths are fake or that the numbers are much smaller than we hear on the news, our research and many other studies on the same subject show quite the opposite,” said lead author Steven Woolf, M.D., director emeritus of VCU’s Center on Society and Health.
The study also contains suggestive evidence that state policies on reopening early in April and May may have fueled the
The 12 human beings who have walked on the moon were all bombarded by radiation roughly 200 times what we experience here on Earth, reports Adam Mann for Science. That’s two to three times what astronauts experience aboard the International Space Station, explains Marcia Dunn for the Associated Press (AP), suggesting that any long term human presence on the moon will require shelters with thick walls capable of blocking the radiation.
Despite the fact that the measurements, which come courtesy of China’s Chang’e-4 lunar lander, are quite high compared to what we experience on Earth, the data is quite useful for protecting future moonwalkers. According to Science, the levels of radiation at the lunar surface wouldn’t be expected to increase the risk of NASA astronauts developing cancer by more than 3 percent—a risk threshold the agency is legally required to keep its astronauts’ activities safely below.
It saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing the same for many of the critically ill COVID-19 patients who receive it, according to a new international study.
The 1,035 patients in the study faced a staggeringly high risk of death, as ventilators and other care failed to support their lungs. But after they were placed on ECMO, their actual death rate was less than 40%. That’s similar to the rate for patients treated with ECMO in past outbreaks of lung-damaging viruses, and other severe forms of viral pneumonia.
The new study published in The Lancet provides strong support for the use of ECMO — short for extracorporeal membrane oxygenation — in appropriate patients as the pandemic rages on worldwide.
It may help more hospitals that have ECMO capability understand which of their COVID-19 patients might benefit from the